| |
| |
|
| Insider
Information: |
Schreiber Alain |
| Relationship: |
10% Owner |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
12,051,047 |
|
|
Indirect Shares
|
11,491,339 |
|
|
| Direct
Value |
$27,342,535 |
|
|
|
Indirect Value
|
$2,610,128 |
|
|
| Total
Shares |
23,542,386 |
|
|
| Total
Value |
$29,952,663 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Molecular Templates, Inc. |
MTEM |
10% Owner |
2005-10-28 |
136,417 |
2005-10-28 |
3,385,203 |
Premium* |
|
|
Palatin Technologies Inc |
PTN |
10% Owner |
2005-11-29 |
5,803,972 |
2005-11-29 |
0 |
Premium* |
|
|
Cadence Pharmaceuticals Inc |
CADX |
Director, 10% Owner |
2007-09-19 |
2,882,269 |
2006-10-30 |
12,500 |
Premium* |
|
|
Optimer Pharmaceuticals Inc |
OPTR |
Director |
2008-07-18 |
2,500 |
2009-03-04 |
811,998 |
Premium* |
|
|
Avanir Pharmaceuticals |
AVNR |
10% Owner |
2008-08-06 |
0 |
2009-10-13 |
7,125,754 |
Premium* |
|
|
Eagle Pharmaceuticals, Inc. |
EGRX |
10% Owner |
|
0 |
2017-05-15 |
155,884 |
Premium* |
|
|
Immune Design Corp. |
IMDZ |
10% Owner |
2015-05-12 |
1,983,858 |
2015-03-05 |
0 |
Premium* |
|
|
Urogen Pharma Ltd. |
URGN |
10% Owner |
2017-11-28 |
1,242,031 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
– – • |
2017-04-25 |
4 |
OE |
$0.90 |
$1,852,677 |
I/I |
54,180 |
60,957 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Director |
– • • |
2015-05-06 |
4 |
D |
$0.00 |
$0 |
I/I |
(9,903) |
62,031 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Director |
– • • |
2014-02-18 |
4 |
A |
$0.00 |
$0 |
I/I |
4,448,591 |
71,934 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Director |
– • • |
2014-02-18 |
4 |
A |
$0.00 |
$0 |
I/I |
4,448,591 |
71,934 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Director |
– • • |
2014-02-18 |
4 |
OE |
$0.00 |
$0 |
I/I |
22,194 |
72,291 |
0 |
- |
|
| MTEM |
Molecular Templates, Inc. |
10% Owner |
– – • |
2005-10-28 |
4 |
S |
$10.46 |
$577,204 |
D/D |
(55,182) |
136,417 |
|
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
10% Owner |
– – • |
2017-05-15 |
4 |
A |
$0.00 |
$0 |
I/I |
298,214 |
149,107 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2008-07-18 |
4 |
B |
$8.48 |
$7,999,998 |
I/I |
943,396 |
628,931 |
2.1 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2009-03-04 |
4 |
B |
$0.00 |
$0 |
I/I |
457,666 |
811,998 |
2.02 |
- |
|
| URGN |
Urogen Pharma Ltd. |
10% Owner |
– – • |
2017-11-28 |
4 |
S |
$40.51 |
$7,202,962 |
D/D |
(177,807) |
1,242,031 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
10% Owner |
– – • |
2017-11-27 |
4 |
S |
$41.12 |
$1,294,910 |
D/D |
(31,491) |
1,419,838 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
10% Owner |
– – • |
2017-05-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,451,329 |
|
- |
|
| IMDZ |
Immune Design Corp. |
10% Owner |
– – • |
2015-05-12 |
4 |
S |
$21.50 |
$3,835,732 |
D/D |
(177,607) |
1,983,858 |
0 |
- |
|
| IMDZ |
Immune Design Corp. |
10% Owner |
– – • |
2015-04-24 |
4 |
S |
$26.64 |
$666,000 |
D/D |
(25,000) |
2,161,465 |
0 |
- |
|
| IMDZ |
Immune Design Corp. |
10% Owner |
– – • |
2015-04-23 |
4 |
S |
$26.64 |
$885,686 |
D/D |
(32,643) |
2,186,465 |
0 |
- |
|
| IMDZ |
Immune Design Corp. |
10% Owner |
– – • |
2015-04-22 |
4 |
S |
$26.56 |
$670,613 |
D/D |
(25,249) |
2,219,108 |
0 |
- |
|
| IMDZ |
Immune Design Corp. |
10% Owner |
– – • |
2015-04-21 |
4 |
S |
$26.35 |
$373,300 |
D/D |
(14,167) |
2,244,357 |
0 |
- |
|
| IMDZ |
Immune Design Corp. |
10% Owner |
– – • |
2015-04-20 |
4 |
S |
$26.44 |
$338,220 |
D/D |
(12,792) |
2,258,524 |
0 |
- |
|
| IMDZ |
Immune Design Corp. |
10% Owner |
– – • |
2015-04-17 |
4 |
S |
$26.67 |
$503,023 |
D/D |
(18,861) |
2,271,316 |
0 |
- |
|
| IMDZ |
Immune Design Corp. |
10% Owner |
– – • |
2015-04-16 |
4 |
S |
$26.75 |
$2,675 |
D/D |
(100) |
2,290,177 |
0 |
- |
|
| IMDZ |
Immune Design Corp. |
10% Owner |
– – • |
2015-04-15 |
4 |
S |
$28.57 |
$1,142,860 |
D/D |
(40,000) |
2,290,277 |
0 |
- |
|
| IMDZ |
Immune Design Corp. |
10% Owner |
– – • |
2015-04-14 |
4 |
S |
$27.26 |
$376,570 |
D/D |
(13,814) |
2,330,277 |
0 |
- |
|
| IMDZ |
Immune Design Corp. |
10% Owner |
– – • |
2015-04-07 |
4 |
S |
$26.55 |
$95,580 |
D/D |
(3,600) |
2,344,091 |
0 |
- |
|
| IMDZ |
Immune Design Corp. |
10% Owner |
– – • |
2015-04-06 |
4 |
S |
$26.88 |
$104,698 |
D/D |
(3,895) |
2,347,691 |
0 |
- |
|
| IMDZ |
Immune Design Corp. |
10% Owner |
– – • |
2015-04-01 |
4 |
S |
$25.51 |
$1,647,148 |
D/D |
(62,454) |
2,351,586 |
0 |
- |
|
117 Records found
|
|
Page 2 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
